resiquimod has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinghorn, GR; Magaret, A; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Spruance, S; Wald, A | 1 |
| Bergland, VA; Corey, L; Huang, ML; Leone, P; Magaret, AS; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Tyring, SK; Wald, A; Warren, T | 1 |
| Martinez, V; Melgar, S | 1 |
| Bernstein, DI; Harrison, CJ; Miller, RL; Tomai, MA | 1 |
1 review(s) available for resiquimod and Recrudescence
| Article | Year |
|---|---|
Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Recurrence | 2002 |
2 trial(s) available for resiquimod and Recrudescence
| Article | Year |
|---|---|
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytokines; Double-Blind Method; Female; Gels; Herpes Simplex; Humans; Imidazoles; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine; Wound Healing; Young Adult | 2014 |
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antiviral Agents; Disease-Free Survival; DNA, Viral; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Virus Shedding | 2007 |
1 other study(ies) available for resiquimod and Recrudescence
| Article | Year |
|---|---|
Lack of colonic-inflammation-induced acute visceral hypersensitivity to colorectal distension in Na(v)1.9 knockout mice.
Topics: Acute Disease; Animals; Catheterization; Colitis; Colon; Female; Hyperalgesia; Imidazoles; Inflammation Mediators; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; NAV1.9 Voltage-Gated Sodium Channel; Neuropeptides; Rectum; Recurrence; Sodium Channels; Stress, Mechanical; Toll-Like Receptor 7 | 2008 |